82_FR_14263 82 FR 14212 - Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting; Amendment

82 FR 14212 - Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting; Amendment

DEPARTMENT OF DEFENSE
Office of the Secretary

Federal Register Volume 82, Issue 51 (March 17, 2017)

Page Range14212-14212
FR Document2017-05347

On Wednesday, February 15, 2017 (82 FR 10762), the Department of Defense published a notice announcing a Federal Advisory Committee Meeting of the Uniform Formulary Beneficiary Advisory Panel. Subsequent to the publication of the notice, an item was added to the Meeting Agenda. All other information in the February 15, 2017 notice remains the same.

Federal Register, Volume 82 Issue 51 (Friday, March 17, 2017) 
[Federal Register Volume 82, Number 51 (Friday, March 17, 2017)]
[Notices]
[Page 14212]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-05347]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee Meeting; Amendment

AGENCY: Assistant Secretary of Defense (Health Affairs), Department of 
Defense.

ACTION: Notice of meeting; amendment.

-----------------------------------------------------------------------

SUMMARY: On Wednesday, February 15, 2017 (82 FR 10762), the Department 
of Defense published a notice announcing a Federal Advisory Committee 
Meeting of the Uniform Formulary Beneficiary Advisory Panel. Subsequent 
to the publication of the notice, an item was added to the Meeting 
Agenda. All other information in the February 15, 2017 notice remains 
the same.

DATES: Wednesday, March 22, 2017, from 9:00 a.m. to 12:00 p.m.

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., 
Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: CAPT Edward Norton, DFO, Uniform 
Formulary Beneficiary Advisory Panel, 7700 Arlington Boulevard, Suite 
5101, Falls Church, VA 22042-5101. Telephone: (703) 681-2890. Fax: 
(703) 681-1940. Email Address: [email protected].

SUPPLEMENTARY INFORMATION: Due to circumstances beyond the control of 
the Designated Federal Officer and the Department of Defense, the 
Uniform Formulary Beneficiary Advisory Panel was unable to provide 
public notification concerning a change to a previously announced 
meeting agenda for a meeting on March 22, 2017, of the Uniform 
Formulary Beneficiary Advisory Panel as required by 41 CFR 102-
3.150(a). Accordingly, the Advisory Committee Management Officer for 
the Department of Defense, pursuant to 41 CFR 102-3.150(b), waives the 
15-calendar day notification requirement.
    This meeting is being held under the provisions of the Federal 
Advisory Committee Act (FACA) of 1972 (5 U.S.C., Appendix, as amended), 
the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), 
and 41 CFR 102-3.140.
    Under the provisions of the Federal Advisory Committee Act of 1972 
(5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 
1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.150, the Department 
of Defense announces that an item in the Meeting Agenda has changed.
    The revised Meeting Agenda reads as follows:

Agenda

1. Sign-In
2. Welcome and Opening Remarks
3. Public Citizen Comments
4. Scheduled Therapeutic Class Reviews (Comments will follow each 
agenda item)
    a. Hepatitis C Agents--Direct Acting Antivirals
    b. Antibiotics--Tetracyclines
    c. Proton Pump Inhibitors
5. Recently Approved Drugs Review
6. Pertinent Utilization Management Issues
7. Panel Discussions and Vote

    Dated: March 13, 2017.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2017-05347 Filed 3-16-17; 8:45 am]
 BILLING CODE 5001-06-P

14212 Federal Register / Vol. 82, No. 51 / Friday, March 17, 2017 / Notices osd.pentagon.ousd-p-r.mbx.family- Dated: March 14, 2017. Under the provisions of the Federal readiness-council@mail.mil. Aaron Siegel, Advisory Committee Act of 1972 (5 SUPPLEMENTARY INFORMATION: This Alternate OSD Federal Register Liaison U.S.C., Appendix, as amended), the meeting is being held under the Officer, Department of Defense. Government in the Sunshine Act of provisions of the Federal Advisory [FR Doc. 2017–05368 Filed 3–16–17; 8:45 am] 1976 (5 U.S.C. 552b, as amended), and Committee Act of 1972 (5 U.S.C. BILLING CODE 5001–06–P 41 CFR 102–3.150, the Department of Appendix, as amended), the Defense announces that an item in the Government in the Sunshine Act of Meeting Agenda has changed. 1976 (5 U.S.C. 552b, as amended), and DEPARTMENT OF DEFENSE The revised Meeting Agenda reads as 41 CFR 102–3.150. follows: Office of the Secretary Pursuant to 5 U.S.C. 552b and 41 CFR Agenda 102–3.140 through 102–3.165, this Uniform Formulary Beneficiary meeting is open to the public, subject to 1. Sign-In Advisory Panel; Notice of Federal 2. Welcome and Opening Remarks the availability of space. Members of the Advisory Committee Meeting; 3. Public Citizen Comments public who are entering the Pentagon Amendment 4. Scheduled Therapeutic Class Reviews should arrive at the Pentagon Visitors (Comments will follow each agenda Center waiting area (Pentagon Metro AGENCY: Assistant Secretary of Defense item) entrance) at 12:00 p.m. on the day of the (Health Affairs), Department of Defense. a. Hepatitis C Agents—Direct Acting meeting to allow time to pass through ACTION: Notice of meeting; amendment. Antivirals security check points and to be escorted b. Antibiotics—Tetracyclines to the meeting location. Members of the SUMMARY: On Wednesday, February 15, c. Proton Pump Inhibitors public need to email their RSVP to the 2017 (82 FR 10762), the Department of 5. Recently Approved Drugs Review Council at osd.pentagon.ousd-p- Defense published a notice announcing 6. Pertinent Utilization Management rmbx.family-readiness-council@mail.mil a Federal Advisory Committee Meeting Issues no later than 5:00 p.m. on Thursday, of the Uniform Formulary Beneficiary 7. Panel Discussions and Vote April 20, 2017 to confirm seating Advisory Panel. Subsequent to the Dated: March 13, 2017. availability, to request an escort, and to publication of the notice, an item was added to the Meeting Agenda. All other Aaron Siegel, request handicapped accessible information in the February 15, 2017 Alternate OSD Federal Register Liaison transportation (cart) if needed. notice remains the same. Officer, Department of Defense. Pursuant to 41 CFR 102–3.105(j) and [FR Doc. 2017–05347 Filed 3–16–17; 8:45 am] 102–3.140, and section 10(a)(3) of the DATES: Wednesday, March 22, 2017, BILLING CODE 5001–06–P Federal Advisory Committee Act of from 9:00 a.m. to 12:00 p.m. 1972, interested persons may submit a ADDRESSES: Naval Heritage Center written statement for review and Theater, 701 Pennsylvania Avenue, consideration by submitting it to the DEPARTMENT OF ENERGY NW., Washington, DC 20004. Council’s email address, FOR FURTHER INFORMATION CONTACT: Federal Energy Regulatory osd.pentagon.ousd-p-r.mbx.family- CAPT Edward Norton, DFO, Uniform Commission readiness-council@mail.mil. The Formulary Beneficiary Advisory Panel, deadline for written submissions is 5:00 7700 Arlington Boulevard, Suite 5101, [Project No. 2788–017] p.m. on Thursday, April 13, 2017 which Falls Church, VA 22042–5101. is two weeks prior to the meeting date. Goodyear Lake Hydro, LLC; Notice of Telephone: (703) 681–2890. Fax: (703) Application Tendered for Filing With The purpose of this meeting is to 681–1940. Email Address: receive information related to the Commission and Soliciting dha.ncr.health-it.mbx.baprequests@ Additional Study Requests and community collaboratives, policies, mail.mil. programs and services that provide Establishing Procedural Schedule for relocation information and support SUPPLEMENTARY INFORMATION: Due to Relicensing and a Deadline for services to DoD Service and family circumstances beyond the control of the Submission of Final Amendments members throughout their mobile Designated Federal Officer and the Take notice that the following military lifecycle. Department of Defense, the Uniform hydroelectric application has been filed Formulary Beneficiary Advisory Panel Thursday, April 27, 2017 Meeting with the Commission and is available was unable to provide public Agenda for public inspection. notification concerning a change to a a. Type of Application: Subsequent Welcome & Administrative Remarks. previously announced meeting agenda Minor License. The Impact of Relocation on Service for a meeting on March 22, 2017, of the b. Project No.: 2788–017. and Family Members. Uniform Formulary Beneficiary c. Date filed: February 27, 2017. High Tech/High Touch Relocation Advisory Panel as required by 41 CFR d. Applicant: Goodyear Lake Hydro, Collaboratives and Support Services. 102–3.150(a). Accordingly, the Advisory LLC (Goodyear Lake Hydro). Committee Management Officer for the e. Name of Project: Colliersville Minnesota’s Beyond the Yellow Department of Defense, pursuant to 41 Hydroelectric Project. Ribbon Support for the National Guard CFR 102–3.150(b), waives the 15- asabaliauskas on DSK3SPTVN1PROD with NOTICES and Reserve. f. Location: On the North Branch of calendar day notification requirement. the Susquehanna River, in the Town of Military OneSource Central This meeting is being held under the Information and Referral Dissemination Milford, Otsego County, New York. The provisions of the Federal Advisory project does not occupy lands of the Point. Committee Act (FACA) of 1972 (5 United States. Military Service Relocation Best U.S.C., Appendix, as amended), the g. Filed Pursuant to: Federal Power Practices (Panel). Government in the Sunshine Act of Act 16 U.S.C. 791 (a)–825(r). Closing Remarks. 1976 (5 U.S.C. 552b, as amended), and h. Applicant Contact: Mr. Kevin Note: Exact order may vary. 41 CFR 102–3.140. Webb, Hydro Licensing Manager; Enel VerDate Sep<11>2014 20:02 Mar 16, 2017 Jkt 241001 PO 00000 Frm 00015 Fmt 4703 Sfmt 4703 E:\FR\FM\17MRN1.SGM 17MRN1


Document Created: 2017-03-17 02:48:53
Document Modified: 2017-03-17 02:48:53
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of meeting; amendment.
DatesWednesday, March 22, 2017, from 9:00 a.m. to 12:00 p.m.
ContactCAPT Edward Norton, DFO, Uniform Formulary Beneficiary Advisory Panel, 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042-5101. Telephone: (703) 681-2890. Fax:
FR Citation82 FR 14212 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR